Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
278
-
Total 13F shares, excl. options
-
59.5M
-
Shares change
-
+2.04M
-
Total reported value, excl. options
-
$6.12B
-
Value change
-
+$226M
-
Put/Call ratio
-
0.46
-
Number of buys
-
129
-
Number of sells
-
-118
-
Price
-
$102.81
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2021
321 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q3 2021.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 278 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.5M shares
of 62.5M outstanding shares and own 95.2% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.58M shares), BlackRock Inc. (5.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.37M shares), FMR LLC (3.21M shares), WELLINGTON MANAGEMENT GROUP LLP (3.2M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.72M shares), STATE STREET CORP (1.69M shares), Casdin Capital, LLC (1.55M shares), JPMORGAN CHASE & CO (1.52M shares), and TimesSquare Capital Management, LLC (1.47M shares).
This table shows the top 278 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.